Amicus Therapeutics Inc (FOLD)
10.54
-0.17
(-1.59%)
USD |
NASDAQ |
Apr 24, 16:00
10.52
-0.02
(-0.19%)
After-Hours: 20:00
Amicus Therapeutics Cash from Investing (TTM): 98.06M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.06M |
| September 30, 2023 | 55.32M |
| June 30, 2023 | 94.07M |
| March 31, 2023 | 70.36M |
| December 31, 2022 | 92.32M |
| September 30, 2022 | 90.93M |
| June 30, 2022 | 50.99M |
| March 31, 2022 | 50.41M |
| December 31, 2021 | 78.76M |
| September 30, 2021 | 124.07M |
| June 30, 2021 | -64.56M |
| March 31, 2021 | -20.26M |
| December 31, 2020 | -13.58M |
| September 30, 2020 | 36.16M |
| June 30, 2020 | 193.41M |
| March 31, 2020 | 108.33M |
| December 31, 2019 | 95.15M |
| September 30, 2019 | 4.389M |
| June 30, 2019 | 115.67M |
| March 31, 2019 | 141.47M |
| December 31, 2018 | -121.20M |
| September 30, 2018 | -5.865M |
| June 30, 2018 | -294.25M |
| March 31, 2018 | -261.43M |
| December 31, 2017 | -171.24M |
| Date | Value |
|---|---|
| September 30, 2017 | -187.43M |
| June 30, 2017 | -43.13M |
| March 31, 2017 | -96.48M |
| December 31, 2016 | -4.509M |
| September 30, 2016 | 45.55M |
| June 30, 2016 | -186.90M |
| March 31, 2016 | -167.45M |
| December 31, 2015 | -145.34M |
| September 30, 2015 | -310.48M |
| June 30, 2015 | -77.89M |
| March 31, 2015 | -79.61M |
| December 31, 2014 | -107.08M |
| September 30, 2014 | -35.31M |
| June 30, 2014 | 14.35M |
| March 31, 2014 | 13.52M |
| December 31, 2013 | 26.08M |
| September 30, 2013 | 50.66M |
| June 30, 2013 | 15.24M |
| March 31, 2013 | 24.02M |
| December 31, 2012 | -39.43M |
| September 30, 2012 | -40.35M |
| June 30, 2012 | -14.80M |
| March 31, 2012 | -21.96M |
| December 31, 2011 | 46.45M |
| September 30, 2011 | -11.86M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-64.56M
Minimum
Jun 2021
193.41M
Maximum
Jun 2020
66.32M
Average
78.76M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| TG Therapeutics Inc | -50.65M |
| Geron Corp | -180.32M |
| Vanda Pharmaceuticals Inc | -12.06M |
| Fate Therapeutics Inc | 112.66M |
| Editas Medicine Inc | -3.731M |